June 18, 2024 – Angiolutions won first place in the competition START HEALTHCARE which was held at the MedtecLIVE Tradefair in Stuttgart.
Angiolutions’ Chief Business Officer, Marius Rummel (fourth from left) with the other winners and the jury.
Angiolutions Chief Business Officer, Marius Rummel, represented the company at the event.
“The journey as a MedTech startup is full of challenges – receiving this endorsement strengthens us on our mission to bring the first treatment to patients that stops abdominal aortic aneurysm in its early stages,” stated Dr. Isabel N. Schellinger, Angiolutions CEO and Co-founder.
Angiolutions revolutionizes the treatment of life-threatening abdominal aortic aneurysms (AAAs) with a first-of-its-kind medical device that stops AAA growth at an early stage. AAA is a progressive dilation of the biggest blood vessel of our body affecting 1 in 20 people. By treating early-stage AAA, Angiolutions brings new hope to hundreds of thousands of patients that are currently without a treatment option.
Please leave your message here